Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.
about
Modeling spinal muscular atrophy in DrosophilaDrug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIA SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA miceIs spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?Spinal muscular atrophy: development and implementation of potential treatmentsMolecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA)Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway.SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophyEarly heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN deliverySustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutritionCardiac defects contribute to the pathology of spinal muscular atrophy modelsRescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulationEffects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyCNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.SMN is required for sensory-motor circuit function in Drosophila.Pathological impact of SMN2 mis-splicing in adult SMA miceProtective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 SplicingTrans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy.Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophySpinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?Spinal muscular atrophy: new and emerging insights from model miceSpinal muscular atrophy: mechanisms and therapeutic strategies.Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse modelInvertebrate models of spinal muscular atrophy: insights into mechanisms and potential therapeutics.Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics.Transcriptome profiling of spinal muscular atrophy motor neurons derived from mouse embryonic stem cellsReduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) geneAnalysis of the fibroblast growth factor system reveals alterations in a mouse model of spinal muscular atrophyDrug discovery and development for spinal muscular atrophy: lessons from screening approaches and future challenges for clinical development.Temporal requirement for high SMN expression in SMA miceSystemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disordersA single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouseAntisense oligonucleotides for the treatment of spinal muscular atrophy.
P2860
Q21562542-667D4C76-E053-4B7D-93D0-3238688071E7Q24200270-1A54D23A-98E5-421C-9FDF-AD1F74AF10EAQ24200377-1E8F3B85-5705-447A-8366-ECDFA0208FC0Q24234414-4DF67E87-539D-4139-9F87-189BECA8F3F7Q24234523-4A3F14BD-9F04-4364-B0A9-AD2CD8836BECQ24241017-E7DB91C1-D51B-4894-8E26-D43EB5E6EFE9Q24241759-7C179AB0-B530-467D-9572-6FE0D655657FQ24657021-89966AF2-9647-4606-891D-C199E7E6B0EBQ26774987-DB32B8B9-E791-4A28-80C5-4D809650E8D7Q26861377-5BA8E680-5044-4CCD-9D1D-D11256B274B6Q27007782-628533ED-9343-4D18-856E-63B831E46EE5Q27312220-B394D06B-7FCF-4BC9-9255-F875D9128AACQ28243993-71A42612-2FE1-41B8-9CEF-083826D2B6CBQ28271235-3B927727-4A01-468E-9519-1BAFA8EFEB9FQ28288188-CE469DAF-6A0C-4879-89C2-57BAF6603A92Q28288824-4E6E1590-4232-4872-A93A-FA2652DAEBF6Q28290032-850FC2C6-B1D5-48B6-B32A-777721871651Q28300972-9EAA3CFE-1D03-469D-A03D-ADF7CD28CD6BQ30492560-1E934E59-0C7F-4F00-82B8-F0E51094856EQ30493891-47CAD503-7868-4ABE-8658-3FDF2904D317Q30525692-B48C54B2-E777-4202-8CF2-322C98310A6CQ30551534-6489C86E-01B9-4E9E-AB14-16DE4E5699D0Q30743508-496A7544-30AA-44FD-BF1C-B2AF555055DDQ30828907-3078924B-2990-43AB-8CB9-2B5AB5C12176Q33720730-6C97759C-8EEA-4BE0-9DA0-A546FA6A4B99Q33730194-96218B94-1EB8-43AF-99A5-687FEAFA8776Q33785933-86EF498E-C646-4CD2-94FB-090D20EBC58DQ33819144-7B770526-04F2-4932-8E17-9B41513AF2FEQ33871311-77BCF4D2-8866-4ABC-969C-C30DC78A8A5EQ34030144-A65254D2-2AC2-4F75-86E0-6FB9263F9063Q34051166-91A7234E-EDA7-43F0-9573-E10BBAB942BDQ34074474-9BC29511-E790-46F6-B9EC-0A59741CF7BDQ34142599-E3B558E2-B92D-4AB1-9E5D-9F00144AEA8DQ34152015-E82B7FA4-C25D-405F-BD71-320B79A666D1Q34163418-00004D84-B6EA-4A1A-BD8D-2B1E372B75D9Q34172502-D2EFEE8F-9BA0-415E-86D0-049857CA8B05Q34192528-CC3C2447-C91F-42D5-9C45-73FE1C199ADDQ34205620-A23A8296-D60B-4AAE-8DBC-7EDDC7CC3A31Q34241874-6F12D7C2-F8AA-4F54-AEC3-78D196BF1E4DQ34336279-BB831DCE-1ED7-4717-8D21-29755F87ED23
P2860
Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Neuronal SMN expression correc ...... sion has no phenotypic effect.
@en
Neuronal SMN expression correc ...... sion has no phenotypic effect.
@nl
type
label
Neuronal SMN expression correc ...... sion has no phenotypic effect.
@en
Neuronal SMN expression correc ...... sion has no phenotypic effect.
@nl
prefLabel
Neuronal SMN expression correc ...... sion has no phenotypic effect.
@en
Neuronal SMN expression correc ...... sion has no phenotypic effect.
@nl
P2093
P2860
P356
P1476
Neuronal SMN expression correc ...... sion has no phenotypic effect.
@en
P2093
Arthur H M Burghes
Christine J DiDonato
Eileen Workman
Glenn E Morris
Rocky G Gogliotti
Tatiana O Gavrilina
Thomas O Crawford
Umrao R Monani
Vicki L McGovern
P2860
P304
P356
10.1093/HMG/DDM379
P577
2008-01-04T00:00:00Z